Interferon alfa–induced sarcoidosis resolving without drug withdrawal José María Ortiz Salvador, MD, Ana Mercedes Victoria Martínez, MD, Daniela Subiabre Ferrer, MD, Victor Alegre de Miquel, MD, PhD, Amparo Pérez Ferriols, MD, PhD JAAD Case Reports Volume 2, Issue 2, Pages 146-149 (March 2016) DOI: 10.1016/j.jdcr.2016.02.003 Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Pulmonary sarcoidosis. A, CT scan shows gross bilateral hilar lymphadenopathy. B, PET-CT shows absorption of fluorodeoxyglucose in the lymph nodes and lung parenchyma. JAAD Case Reports 2016 2, 146-149DOI: (10.1016/j.jdcr.2016.02.003) Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 Cutaneous sarcoidosis. A, Skin-colored papules and nodules in the sole of the patient. B, Nodule developed in the scar of a previous surgery. JAAD Case Reports 2016 2, 146-149DOI: (10.1016/j.jdcr.2016.02.003) Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions
Fig 3 Cutaneous sarcoidosis. Skin biopsy. A, Granulomatous infiltrate affecting the whole dermis. B, Naked noncaseating granulomas without peripheral rim of lymphocytes (sarcoidal granuloma). Inset, Langhans type multinucleated giant cell. (A and B, Hematoxylin-eosin stain; original magnifications: A, ×20; B, ×40.). JAAD Case Reports 2016 2, 146-149DOI: (10.1016/j.jdcr.2016.02.003) Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions